Structure-activity relationship of C4-substituted pyrimidopyrimidines; Dual KDR/FGFR tyrosine kinase inhibitors.

被引:0
|
作者
Rossman, P
Luk, K
Chen, Y
Garafalo, L
Graves, B
Jackson, N
Kabat, M
Konzelmann, F
Liu, JJ
Lukacs, C
McDermott, L
Michoud, C
Portland, L
Roberts, J
Schutt, A
Simcox, M
So, SS
Tamborini, B
Yang, H
机构
[1] Hoffmann La Roche Inc, Discovery Chem, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Chem Synth, Nutley, NJ 07110 USA
[3] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
124-MEDI
引用
收藏
页码:U129 / U129
页数:1
相关论文
共 50 条
  • [1] MEDI 123-Design, synthesis and structure activity relationship within a series of 4-amino-thienopyridines, dual KDR/FGFR tyrosine kinase inhibitors
    Chen, Y.
    Luk, K.
    Flynn, T.
    McDermott, L.
    Morales, Omar
    Rossman, P.
    Simcox, M.
    So, S-S.
    Wovkulich, P.
    Yang, H.
    Zhang, Z.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [2] Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors
    Lee, Jongkook
    Han, Sun-Young
    Jung, Heejung
    Yang, Jeon
    Choi, Jie-Won
    Chae, Chong Hack
    Park, Chi Hoon
    Choi, Sang Un
    Lee, Kwangho
    Du Ha, Jae
    Lee, Chong Ock
    Ryu, Jae Wook
    Kim, Hyoung Rae
    Koh, Jong Sung
    Cho, Sung Yun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4044 - 4048
  • [3] Structure-Activity Relationship of Halophenols as a New Class of Protein Tyrosine Kinase Inhibitors
    Feng, Xiu E.
    Zhao, Wan Yi
    Ban, Shu Rong
    Zhao, Cheng Xiao
    Li, Qing Shan
    Lin, Wen Han
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (09) : 6104 - 6115
  • [4] Quantitative structure-activity relationship of flavonoid p56(lck) protein tyrosine kinase inhibitors. A neural network approach
    Novic, M
    NikolovskaColeska, Z
    Solmajer, T
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1997, 37 (06): : 990 - 998
  • [5] Amino substituted nitrogen heterocycle ureas as kinase insert domain containing receptor (KDR) inhibitors: Performance of structure-activity relationship approaches
    Yilmaz, Hayriye
    Sizochenko, Natalia
    Rasulev, Bakhtiyor
    Toropov, Andrey
    Guzel, Yahya
    Kuz'min, Viktor
    Leszczynska, Danuta
    Leszczynski, Jerzy
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2015, 23 (02) : 168 - 175
  • [6] Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors
    Qiao, Lixin
    Choi, Sungwoon
    Case, April
    Gainer, Thomas G.
    Seyb, Kathleen
    Glicksman, Marcie A.
    Lo, Donald C.
    Stein, Ross L.
    Cuny, Gregory D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6122 - 6126
  • [7] Three-dimensional quantitative structure-activity relationship study of tyrosine kinase inhibitors
    Peng, T
    Pei, HF
    Zhou, JJ
    ACTA PHYSICO-CHIMICA SINICA, 2003, 19 (02) : 163 - 166
  • [8] Structure-activity relationships of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.
    Connolly, CJC
    Hamby, JM
    Schroeder, MC
    Lu, GH
    Panek, L
    Amar, A
    Shen, C
    Kraker, AJ
    Doherty, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 193 - MEDI
  • [9] Quantitative structure-activity relationship for the cleavage of C3/C4-substituted catechols by a prototypal extradiol catechol dioxygenase with broad substrate specificity
    Ishida, T
    Tanaka, H
    Horiike, K
    JOURNAL OF BIOCHEMISTRY, 2004, 135 (06): : 721 - 730
  • [10] Structure-activity relationship studies of sphingosine kinase inhibitors
    Raje, Mithun R.
    Kharel, Yugesh
    Lynch, Kevin R.
    Santos, Webster L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240